학술논문

The Cost-Effectiveness of Intermediate-Acting, Long-Acting, Ultralong-Acting, and Biosimilar Insulins for Type 1 Diabetes Mellitus: A Systematic Review
Document Type
Review Article
Source
In Value in Health July 2022 25(7):1235-1252
Subject
Language
ISSN
1098-3015